In recent years, China Resources Group has sold shares of subsidiaries such as China Resources Wandong and Shanghai Medical Devices Group, and Dongya Ejiao Co., Ltd., a core subsidiary of China Resources Group, announced that it intends to transfer 36% of its shares to Dong'e Ejiao Medical. The shares of Instrument Co., Ltd. (hereinafter referred to as "Ahua Medical Devices"). It is widely said that China Resources Pharmaceuticals has lost health care.
According to industry insiders, after the completion of the transaction, it marks that China Resources will completely withdraw from the medical machinery field. The industry is optimistic about the prospects of China Resources' selling of medical machinery assets. Some people even believe that China Resources Group has divested its medical device business, indicating that China Resources Medical Development is unfavorable.
Song Lin, the former chairman of China Resources Group, was investigated for serious violations of the law. Fu Yuning, the successor of Song Lin, continued to implement Song Lin’s established strategy in dealing with medical device assets. Earlier, China Resources executives said that the group is not optimistic about the medical device industry . The reason is that multinational medical device giants occupy the high-end medical device market, while domestic companies are mostly manufacturing low-end products with low-cost manufacturing advantages. However, the industry belongs to the technology-investment industry, and there are insufficient technical inputs, limited research and development, and difficult long-term development. From the long-term strategy, China Resources chose to sell medical machinery based on the business benefits that could not meet the expectations of the group.
The industry questioned the correctness of China Resources' sales in the development of the domestic medical device market. The data shows that the sales scale of China's medical device market has increased from 17.9 billion yuan in 2001 to 255.6 billion yuan in 2014. After excluding the impact of prices and other factors, it has increased by about 14 times in 14 years. Medical devices are eye-catching in the key business segments of China Resources Group. The profitability of other areas of health care, such as medical institutions and R&D and production, is clearly lower than that of medical devices.
Under the background of the development of a large health industry proposed by the central government, the huge demand for medical devices has been released. At this time, it is the first choice to continue to adhere to the field of medical machinery. In addition, China Resources Medical is the target of Sinopharm Group and Shanghai Pharmaceutical Group, which all have medical machinery business. It is not a smart choice to sell its own medical device business.
Veterinary drugs can be roughly classified into four categories: â‘ general disease control drugs; â‘¡ infectious disease control drugs; â‘¢ internal and external parasitic disease control drugs; â‘£ (including growth-promoting drugs). Except for Biochemical immune products (bacteria, vaccines, serums, antitoxins and toxoids, etc.) for the prevention and treatment of infectious diseases, and special veterinary drugs such as special parasitic drugs for livestock and poultry and growth-promoting drugs, the rest are the same as those for human use, but the dosage , dosage forms and specifications are different. It has long been widely used to control livestock and poultry diseases.
Among veterinary drugs, commonly used are more than 20 kinds such as analgin, amoxicillin, florfenicol, ceftiofur, oxytetracycline, chlortetracycline, bacitracin, salinomycin, monensin, colistin, etc. . 60% of antibiotics are used for chemical treatment; 40% are used for chemical treatment, which not only has the effect of preventing infectious diseases, but also can promote the growth of livestock and poultry and improve the utilization rate of feed.
Veterinary Raw list,Tulathromycin A Powder Prcie,Bulk Ethopabate Powder Price,Norfloxacin Powder Price,Isoprenaline Hydrochloride Powder
Xi'an Henrikang Biotech Co.,Ltd , https://www.henruikangbio.com